microdosing glp 1 dr tyna The Truth About GLP-1s And Metabolic Health, With Dr. Moore Thinking About Microdosing GLP-1? 5

After 6 months, those taking the semaglutide had average blood sugar reductions of 0.6% to 1.1%, with bodyweight reduction of around 5 pounds for the 14-mg dose

However, if you also have CKD stage 3a, HFpEF, or uncontrolled hypertension on two medications, you qualify under Tier 2 by meeting the cardiovascular or kidney condition (not by diabetes)

Together these effects reduce hunger and help your body use stored energy more efficiently

Long-term GLP-1 use appears safe based on available clinical data, though individual tolerance can vary

These experiences motivated us to develop a safer, more natural, and more effective approach to metabolic health and weight management